Lv3
250 积分 2021-08-03 加入
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
18小时前
待确认
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
8天前
已完结
Updates in Pathogenesis of Pemphigus Vulgaris
17天前
已完结
Whole blood hydroxychloroquine: Does genetic polymorphism of cytochrome P450 enzymes have a role?
25天前
已完结
Rituximab beyond oncology: targeting B-cell-mediated immunomodulatory therapy in neurodegenerative and neuropsychiatric disorders
27天前
已完结
T-cell engagers in rheumatology
29天前
已完结
T cell engagers in autoimmune diseases
29天前
已完结
New biological agents in systemic lupus erythematosus
1个月前
已完结
Advances in the treatment of systemic lupus erythematosus
1个月前
已完结
New biologics and targeted therapies in systemic lupus: From new molecular targets to new indications. A systematic review
1个月前
已完结
皖公网安备34019202002308
